Phase 4 Study, Assessing the Efficacy of Lansoprazole and Domperidone Combination on Intragastric and Intraesophageal Acidity

NCT02958046 Phase 4 COMPLETED

The purpose of this study is to investigate the efficacy of lansoprazole combination with domperidone on intragastric acidity and intraesophageal acidity, GERD symptoms, impedance kinetics, gastric emptying in patients with gastroesophageal reflux disease (GERD).

Details

Lead sponsor	Neutec Ar-Ge San ve Tic A.Ş
Phase	Phase 4
Status	COMPLETED
Enrolment	12
Start date	2014-01
Completion	2015-08

Conditions

• Gastroesophageal Reflux Disease

Interventions

• Lansoprazole/Domperidone

Primary outcomes

• The percentage time of 24-hour intragastric pH >4 compared to baseline — 7 days
• The AUC of 24-hour intragastric pH >4 compared to baseline — 7 days

Countries

Turkey (Türkiye)